VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Vyant Bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$27.4K
2
-$22.5K
3
-$16.1K
4
BlackRock
BlackRock
New York
-$15.4K
5
Millennium Management
Millennium Management
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
–
Geode Capital Management
2
Geode Capital Management
Massachusetts
–
MC
3
Mayo Clinic
Minnesota
–
BlackRock
4
BlackRock
New York
–
Millennium Management
5
Millennium Management
New York
–
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
–
State Street
7
State Street
Massachusetts
–
Renaissance Technologies
8
Renaissance Technologies
New York
–
VF
9
Virtu Financial
New York
–
UBS Group
10
UBS Group
Switzerland
–
US Bancorp
11
US Bancorp
Minnesota
–
TRCT
12
Tower Research Capital (TRC)
New York
–
Wells Fargo
13
Wells Fargo
California
–
Osaic Holdings
14
Osaic Holdings
Arizona
–
Morgan Stanley
15
Morgan Stanley
New York
–